Why did this ASX All Ords stock just crash 17%?

Why is this stock being sold off? Let's see what investors are not happy about.

| More on:
Frustrated and shocked business woman reading bad news online from phone.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

AVITA Medical Inc (ASX: AVH) shares are having a tough time on Wednesday.

In morning trade, the ASX All Ords stock is down 17% to $3.62.

Why is this ASX All Ords stock down 17%?

This commercial-stage regenerative medicine company's shares are being sold off this morning after it revealed a softer-than-expected finish to FY 2024.

According to the release, demand for its wound care management and skin restoration devices was below expectations in the fourth quarter. As a result, it now expects commercial revenue to be approximately US$18.4 million for the three months.

While this represents growth of around 30% over the prior corresponding period, it is short of its fourth-quarter guidance range of US$22.3 million to US$24.3 million.

As a result, its revenue in FY 2024 is also going to be short of guidance. Management expects its full year commercial revenue to be approximately US$64.3 million, reflecting growth of about 29% over FY 2023.

Whereas it previously provided FY 2024 revenue guidance of US$68 million to US$70 million.

What went wrong?

The ASX All Ords stock revealed that its guidance miss reflects a combination of factors.

However, slower-than-expected purchasing activity is the primary driver. It notes that several of the company's hospital accounts adjusted their inventory levels at the end of their fiscal year, resulting in reduced purchasing during December.

And while this type of behaviour is common at year-end, the extent was more pronounced than AVITA Medical had anticipated, contributing to less revenue in the quarter.

The good news is that the ASX All Ords stock is expecting normal purchasing activity for these accounts to resume in the first quarter, with deferred purchases from the fourth quarter rolling over.

Commenting on the full year, AVITA Medical CEO Jim Corbett said:

We grew our revenue in 2024 by approximately 29% over the prior year. We achieved this growth despite lower-than-expected fourth-quarter revenue.

We remain confident in our long-term growth trajectory as we continue to scale our business. Our strategic investments in our people and new products position us to continue to drive significant growth and sustainable success. We are focused on executing our plan, delivering value to our shareholders, and improving patient outcomes.

Looking ahead, the company is guiding to commercial revenue in the range of US$100 million to US$106 million in FY 2025. This reflects growth of approximately 55% to 65% over the projected FY 2024 commercial revenue.

Though, it now expects to achieve cash flow break-even and GAAP profitability in the fourth quarter of 2025, instead of the third quarter of 2025.

Should you invest $1,000 in Avita Medical right now?

Before you buy Avita Medical shares, consider this:

Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now... and Avita Medical wasn't one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

And right now, Scott thinks there are 5 stocks that may be better buys...

See The 5 Stocks *Returns as of 30 April 2025

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Avita Medical. The Motley Fool Australia has recommended Avita Medical. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Fallers

A young male investor wearing a white business shirt screams in frustration with his hands grasping his hair after ASX 200 shares fell rapidly today and appear to be heading into a stock market crash
Share Fallers

Why Appen, DroneShield, Gentrack, and New Hope shares are dropping today

These shares are starting the week in the red. But why?

Read more »

A young man clasps his hand to his head with his eyes closed and a pained expression on his face as he clasps a laptop computer in front of him, seemingly learning of bad news or a poor investment.
Share Fallers

Why Dexus, Dusk, Fletcher Building, and Paladin Energy shares are falling today

These shares are ending the week in the red. But why?

Read more »

Couple look at a bottle of wine while trying to decide what to buy.
Consumer Staples & Discretionary Shares

Treasury Wine shares: Buy, hold, or sell? Here's Macquarie's take

What is Macquarie forecasting for Treasury Wine shares amid the CEO’s unexpected exit?

Read more »

A man sits in despair at his computer with his hands either side of his head, staring into the screen with a pained and anguished look on his face, in a home office setting.
Share Fallers

Why Newmont, NRW, Peet, and Treasury Wine shares are dropping today

Let's find out why investors are selling down these shares on Thursday.

Read more »

A male investor wearing a blue shirt looks off to the side with a miffed look on his face as the share price declines.
Share Fallers

Why Aristocrat, EBR, GQG, and Insignia shares are tumbling today

These shares are having a tough time on hump day. Let's find out why.

Read more »

A young man clasps his hand to his head with his eyes closed and a pained expression on his face as he clasps a laptop computer in front of him, seemingly learning of bad news or a poor investment.
Share Fallers

Why Healius, Light & Wonder, REA Group, and Regis Resources shares are falling today

These shares are ending the week in the red. Let's find out why.

Read more »

A man sits in despair at his computer with his hands either side of his head, staring into the screen with a pained and anguished look on his face, in a home office setting.
Share Fallers

Why ANZ, Brainchip, Light & Wonder, and Pilbara Minerals shares are falling today

These shares are tumbling on Thursday. But why?

Read more »

A male investor wearing a blue shirt looks off to the side with a miffed look on his face as the share price declines.
Share Fallers

Why Aurizon, JB Hi-FI, Nuix, and Platinum shares are tumbling today

These shares are falling on hump day. But why?

Read more »